Skip to content
★ Sign in to follow
LH

Li Huimin

China Shineway Pharmaceutical Group Ltd.
Total declarations
7
Company
1
▲ Purchases (6 ops.)
€799k
▼ Sales (1 ops.)
—

Latest filing published 07 Dec 2017 for China Shineway Pharmaceutical Group Ltd., €15k.

Filing timeline

BuySale
Li Huimin

Insider track record

Disclosed buys
6
Disclosed sells
1
Signal history

Closed purchases

Market purchases
6
Positive at T+90
100%
Median T+90
+51.0%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Li Huimin: trading record in brief

This profile gathers the share dealings of Li Huimin in China Shineway Pharmaceutical Group Ltd. The record holds 7 filings, for trades running from 20 November 2017 to 5 December 2017.

The open-market side counts 6 purchases for €799k alongside 1 sale. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The median purchase comes to €142k. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days. After 5 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +51.0%. These figures describe past trades and do not predict future prices.

On 7 December 2017 came the latest disclosure, an open-market purchase for €15k in China Shineway Pharmaceutical Group Ltd. The median gap between a trade and its publication by HKEX is 2 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Li Huimin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total

7 of 7 declarations